Sponsor:
Diality Inc.
Code:
NCT06613568
Conditions
End Stage Kidney Disease
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Moda-flx Hemodialysis System™
Brief summary:
Conditions
End Stage Kidney Disease
Study ID
NCT06613568
Start date
Oct 6, 2025
Status verified date
Aug, 2025
Completion date
Sep, 2027
Anticipated
Primary completion date
Mar, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
50 participants
Anticipated
Intervention Model
Single group
Primary purpose
Treatment
Arms
experimental: Professional Care and At Home
Interventions
Moda-flx Hemodialysis System™
Primary outcome measure
Central contacts
Locations
North America Research Institute
Recruiting
San Dimas, California, United States, 91773
Contacts
New York Kidney Hypertension Medicine
Recruiting
New Hyde Park, New York, United States, 11040
Contacts
Nephrology Associates of Knoxville
Recruiting
Knoxville, Tennessee, United States, 37920
Contacts
aQua Research Institute, LLC
Recruiting
Houston, Texas, United States, 77058
Contacts
University of Washington
Recruiting
Seattle, Washington, United States, 98104
Contacts
Lori Linke
linkel@uw.eduSponsor
Diality Inc.
Last update posted
Jul 6, 2026
Last verified
Aug, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Diality Inc. on 2026-07-06.